Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
950.53
956.05
654.81
620.39
665.21
478.71
486.26
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
950.53
956.05
654.81
620.39
665.21
478.71
486.26
Raw Material Cost
871.88
874.45
583.74
555.91
622.86
412.48
420.25
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
17.52
17.72
7.38
7.31
8.07
8.86
8.59
Selling and Distribution Expenses
60.25
62.39
50.73
43.90
41.63
37.80
35.95
Other Expenses
-1.75
-1.77
-0.74
-0.73
-0.81
-0.89
-0.86
Total Expenditure (Excl Depreciation)
932.13
936.84
634.47
599.81
664.49
450.29
456.20
Operating Profit (PBDIT) excl Other Income
18.400000000000002
19.2
20.299999999999997
20.6
0.7000000000000001
28.4
30.099999999999998
Other Income
5.86
4.99
3.85
-3.63
5.14
7.80
10.63
Operating Profit (PBDIT)
40.66
39.79
31.10
23.80
13.98
43.49
48.13
Interest
17.52
17.72
7.38
7.31
8.07
8.86
8.59
Exceptional Items
0.77
-0.81
0.01
-0.04
0.32
-0.56
-0.21
Gross Profit (PBDT)
78.64
81.60
71.06
64.48
42.35
66.23
66.02
Depreciation
16.40
15.60
6.90
6.85
8.13
7.26
7.44
Profit Before Tax
7.51
5.67
16.82
9.60
-1.90
26.81
31.90
Tax
0.94
4.59
6.61
3.38
5.88
7.83
10.03
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
6.00
0.37
9.42
6.69
-6.95
16.09
19.17
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
6.00
0.37
9.42
6.69
-6.95
16.09
19.17
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.56
0.70
0.79
-0.47
-0.83
2.89
2.69
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
6.56
1.08
10.22
6.22
-7.78
18.98
21.87
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
779.29
775.54
765.46
745.37
712.72
704.62
678.87
Earnings per share (EPS)
0.12
0.01
0.19
0.14
-0.14
0.33
0.4
Diluted Earnings per share
0.12
0.01
0.19
0.14
-0.14
0.33
0.4
Operating Profit Margin (Excl OI)
1.94%
2.01%
3.11%
3.32%
0.11%
5.94%
6.18%
Gross Profit Margin
2.52%
2.22%
3.62%
2.65%
0.94%
7.12%
8.09%
PAT Margin
0.63%
0.04%
1.44%
1.08%
-1.04%
3.36%
3.94%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Dec 2025 is -0.58% vs 46.00% in Sep 2025
Consolidate Net Profit
QoQ Growth in quarter ended Dec 2025 is 500.00% vs -89.22% in Sep 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Dec 2025 is 0.00% vs 27.94% in Sep 2025
Interest
QoQ Growth in quarter ended Dec 2025 is -1.13% vs 139.19% in Sep 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025
Compare Quarterly Results Of Astrana Health, Inc. With
Figures in Million
Consolidate Quarterly Results
Change(USD)
Change(%)
Net Sales
950.53
2,806.00
-1,855.47
-66.13%
Other Operating Income
0.00
0.00
0.00
Total Operating income
950.53
2,806.00
-1,855.47
-66.13%
Raw Material Cost
871.88
1,929.00
-1,057.12
-54.80%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
17.52
67.00
-49.48
-73.85%
Selling and Distribution Expenses
60.25
486.00
-425.75
-87.60%
Other Expenses
-1.75
-6.70
4.95
73.88%
Total Expenditure (Excl Depreciation)
932.13
2,415.00
-1,482.87
-61.40%
Operating Profit (PBDIT) excl Other Income
18.39
391.00
-372.61
-95.30%
Other Income
5.86
30.00
-24.14
-80.47%
Operating Profit (PBDIT)
40.66
566.00
-525.34
-92.82%
Interest
17.52
67.00
-49.48
-73.85%
Exceptional Items
0.77
-24.00
24.77
103.21%
Gross Profit (PBDT)
78.64
877.00
-798.36
-91.03%
Depreciation
16.40
145.00
-128.60
-88.69%
Profit Before Tax
7.51
330.00
-322.49
-97.72%
Tax
0.94
81.00
-80.06
-98.84%
Provisions and contingencies
0
0
0.00
Profit After Tax
6.00
245.00
-239.00
-97.55%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
6.00
245.00
-239.00
-97.55%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.56
11.00
-10.44
-94.91%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
6.56
256.00
-249.44
-97.44%
Equity Capital
0
0
0.00
Face Value
0.00
0.01
0.00
Reserves
779.29
7,170.00
-6,390.71
-89.13%
Earnings per share (EPS)
0.12
2.19
-2.07
-94.52%
Diluted Earnings per share
0.12
2.19
-2.07
-94.52%
Operating Profit Margin (Excl OI)
1.94%
13.93%
0.00
-11.99%
Gross Profit Margin
2.52%
16.93%
0.00
-14.41%
PAT Margin
0.63%
8.73%
0.00
-8.10%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 95.05 Million
in Dec 2025Figures in Million
QoQ Growth in quarter ended Dec 2025 is -0.58% vs 46.00% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 42.89% vs 88.44% in Dec 2024
Quarterly - Consolidate Net Profit
Consolidate Net Profit 0.66 Million
in Dec 2025Figures in Million
QoQ Growth in quarter ended Dec 2025 is 500.00% vs -89.22% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 184.62% vs -7,700.00% in Dec 2024
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 3.48 Million
in Dec 2025Figures in Million
QoQ Growth in quarter ended Dec 2025 is 0.00% vs 27.94% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 295.45% vs 780.00% in Dec 2024
Quarterly - Interest
Interest 1.75 Million
in Dec 2025Figures in Million
QoQ Growth in quarter ended Dec 2025 is -1.13% vs 139.19% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 116.05% vs 50.00% in Dec 2024
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 1.94%
in Dec 2025Figures in %
QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025
YoY Growth in quarter ended Dec 2025 has improved from Dec 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
